Published in BMC Med Inform Decis Mak on September 04, 2015
A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care (1996) 70.87
The estimation of a preference-based measure of health from the SF-36. J Health Econ (2002) 14.18
Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making (1998) 5.14
The Nottingham Health Profile: subjective health status and medical consultations. Soc Sci Med A (1981) 5.02
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health (2013) 4.22
Utilities and quality-adjusted life years. Int J Technol Assess Health Care (1989) 4.18
The 15D instrument of health-related quality of life: properties and applications. Ann Med (2001) 3.31
A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ (2009) 2.91
Handling uncertainty when performing economic evaluation of healthcare interventions. Health Technol Assess (1999) 2.63
Generalisability in economic evaluation studies in healthcare: a review and case studies. Health Technol Assess (2004) 2.38
Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force. Value Health (2013) 2.20
State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--3. Value Health (2012) 1.90
Mapping to obtain EQ-5D utility values for use in NICE health technology assessments. Value Health (2013) 1.44
Can economic evaluations be made more transferable? Eur J Health Econ (2005) 1.27
Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database. Health Qual Life Outcomes (2013) 1.27
Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another. Curr Med Res Opin (2007) 1.23
Economic evaluation of pharmaceuticals. Frankenstein's monster or vampire of trials? Med Care (1996) 1.21
Early assessment of medical technologies to inform product development and market access: a review of methods and applications. Appl Health Econ Health Policy (2011) 1.13
Integrating health economics modeling in the product development cycle of medical devices: a Bayesian approach. Int J Technol Assess Health Care (2008) 1.10
Characterizing structural uncertainty in decision analytic models: a review and application of methods. Value Health (2011) 1.02
Improving early cycle economic evaluation of diagnostic technologies. Expert Rev Pharmacoecon Outcomes Res (2014) 0.96
Integrating health economics into the product development cycle: a case study of absorbable pins for treating hallux valgus. Med Decis Making (2010) 0.89
EQUIPT: protocol of a comparative effectiveness research study evaluating cross-context transferability of economic evidence on tobacco control. BMJ Open (2014) 0.87
Customising an international disease management model to the needs of individual countries. Application to upper gastrointestinal disease. Pharmacoeconomics (1998) 0.80
Mind the Gap! A Multilevel Analysis of Factors Related to Variation in Published Cost-Effectiveness Estimates within and between Countries. Med Decis Making (2015) 0.79
Transferability of economic evaluations of medical technologies: a new technology for orthopedic surgery. Expert Rev Med Devices (2008) 0.79
Engaging with economic evaluation methods: insights from small and medium enterprises in the UK medical devices industry after training workshops. Health Res Policy Syst (2012) 0.78
A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ (2009) 2.91
Neural foundations to moral reasoning and antisocial behavior. Soc Cogn Affect Neurosci (2006) 1.67
Cell-to-cell miRNA transfer: from body homeostasis to therapy. Pharmacol Ther (2012) 1.27
Increased volume of the striatum in psychopathic individuals. Biol Psychiatry (2010) 1.22
The first stage of developing preference-based measures: constructing a health-state classification using Rasch analysis. Qual Life Res (2008) 1.14
Neurodevelopmental marker for limbic maldevelopment in antisocial personality disorder and psychopathy. Br J Psychiatry (2010) 1.00
The use of rasch analysis in reducing a large condition-specific instrument for preference valuation: the case of moving from AQLQ to AQL-5D. Med Decis Making (2010) 0.96
The neurobiology of psychopathy: a neurodevelopmental perspective. Can J Psychiatry (2009) 0.96
The potential role of the striatum in antisocial behavior and psychopathy. Biol Psychiatry (2012) 0.96
The validity of generic and condition-specific preference-based instruments: the ability to discriminate asthma control status. Qual Life Res (2008) 0.94
Mapping corticocortical structural integrity in schizophrenia and effects of genetic liability. Biol Psychiatry (2011) 0.93
Integrating health economics into the product development cycle: a case study of absorbable pins for treating hallux valgus. Med Decis Making (2010) 0.89
Integrated personal health and care services deployment: experiences in eight European countries. Int J Med Inform (2013) 0.89
A method for the early health technology assessment of novel biomarker measurement in primary prevention programs. Stat Med (2012) 0.88
The impact of adding an extra dimension to a preference-based measure. Soc Sci Med (2011) 0.86
Ocular complications of human immunodeficiency virus infection in eastern china. Am J Ophthalmol (2011) 0.85
Liver fat reduction with niacin is influenced by DGAT-2 polymorphisms in hypertriglyceridemic patients. J Lipid Res (2012) 0.84
Comparison of adhesive gut bacteria composition, immunity, and disease resistance in juvenile hybrid tilapia fed two different Lactobacillus strains. Fish Shellfish Immunol (2013) 0.83
Exploring the role of ICT in the provision of integrated care--evidence from eight countries. Health Policy (2013) 0.82
A systematic review of the evidence for the effectiveness of dance therapy. Altern Ther Health Med (2011) 0.82
Comparison of health state utility values derived using time trade-off, rank and discrete choice data anchored on the full health-dead scale. Eur J Health Econ (2011) 0.81
No volumetric differences in the anterior cingulate of psychopathic individuals. Psychiatry Res (2010) 0.80
EXOGEN ultrasound bone healing system for long bone fractures with non-union or delayed healing: a NICE medical technology guidance. Appl Health Econ Health Policy (2014) 0.80
Primum non nocere: shared informed decision making in low back pain--a pilot cluster randomised trial. BMC Musculoskelet Disord (2014) 0.79
Increased executive functioning, attention, and cortical thickness in white-collar criminals. Hum Brain Mapp (2011) 0.79
Determination of estrogens in human urine by high-performance liquid chromatography/diode array detection with ultrasound-assisted cloud-point extraction. Anal Biochem (2011) 0.78
Lactobacillus planarum subsp. plantarum JCM 1149 vs. Aeromonas hydrophila NJ-1 in the anterior intestine and posterior intestine of hybrid tilapia Oreochromis niloticus ♀ × Oreochromis aureus ♂: an ex vivo study. Fish Shellfish Immunol (2013) 0.78
Structural and psychosocial correlates of birth order anomalies in schizophrenia and homicide. J Nerv Ment Dis (2010) 0.76
Resting EEG deficits in accused murderers with schizophrenia. Psychiatry Res (2011) 0.76
Neurocriminology. Adv Genet (2011) 0.75
Utility of 4-chloro-7-nitrobenzofurazan for the spectrofluorimetric determination of butylated hydroxyanisole and propyl gallate in foodstuffs. J Food Sci (2012) 0.75
Supramolecular solvent-based vortex-mixed microextraction: determination of glucocorticoids in water samples. J Chromatogr A (2013) 0.75
Study on the determination of heavy metals in water samples with ultrasound-assisted dispersive liquid-liquid microextraction prior to FAAS. Water Sci Technol (2013) 0.75
Ultrasonic-assisted cloud point extraction for determination of nickel in water samples by flame atomic absorption spectrometry. Water Sci Technol (2012) 0.75
[Mitochondrial tRNA(Thr)T15943C mutation may be a new position that affects the phenotypic expression of deafness associated 12s rRNA A1555G mutation]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi (2015) 0.75
Enabling Equal Access to Molecular Diagnostics: What Are the Implications for Policy and Health Technology Assessment? Public Health Genomics (2016) 0.75
The clinical research of the endoscopic sequential treatment for patients with intermediate-advanced esophageal cancer: a randomized clinical trial. Med Oncol (2014) 0.75
Cloud-point extraction and reversed-phase high-performance liquid chromatography for the determination of synthetic phenolic antioxidants in edible oils. J Food Sci (2010) 0.75
Aluminium sensitized spectrofluorimetric determination of fluoroquinolones in milk samples coupled with salting-out assisted liquid-liquid ultrasonic extraction. Spectrochim Acta A Mol Biomol Spectrosc (2012) 0.75
Spectrofluorimetric determination of fluoroquinolones in honey with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone in the presence of β-cyclodextrin. J Fluoresc (2013) 0.75